Table 2.
Prevention Performance Based on Development Data Set
Measure (% Correct) | |||||
---|---|---|---|---|---|
Variable | Total | Vaccine | Vascular-related | Cancer Screening | Personal Behaviors |
Site | |||||
1 | 40 | 5 | 31 | 17 | 69 |
2 | 61 | 47 | 44 | 43 | 82 |
3 | 67 | 42 | 48 | 49 | 93 |
4 | 65 | 51 | 46 | 51 | 88 |
Training level | |||||
PGY2 | 60 | 32 | 41 | 41 | 87 |
PGY3 | 60 | 42 | 46 | 39 | 83 |
Attending | 55 | 36 | 39 | 41 | 79 |
Condition | |||||
COPD 1 | 60 | 33 | 31 | 54 | 87 |
COPD 2 | 48 | 37 | 19 | 33 | 82 |
Diabetes 1 | 65 | 41 | 47 | n/a* | 85 |
Diabetes 2 | 63 | 29 | 61 | 42 | 83 |
Vascular 1 | 56 | 25 | 46 | 37 | 84 |
Vascular 2 | 53 | 35 | 38 | 35 | 81 |
Depression 1 | 57 | 36 | 48 | 38 | 81 |
Depression 2 | 63 | 56 | 49 | n/a* | 80 |
Prompt by patient | |||||
Yes | 61 | 39 | 44 | 46 | 85 |
No | 47 | 30 | 33 | 24 | 72 |
Using the developmental data set, overall and category-specific prevention scores (% correct) are displayed according to site, training level, clinical condition, and prompt by patient.
Cancer screening strategies were not applicable to these cases due to age of cases.
PGY, postgraduate year; COPD, chronic obstructive pulmonary disease.